Boston Scientific (NYSE:BSX) today reduced its 2026 guidance despite second-quarter results that came in ahead of the consensus forecast.
Original Image Link
Source:www.massdevice.com
Original Image Link
Source:www.massdevice.com
Posted: 2026-07-29 03:40:00
















